Sphingosine- and ceramide-analog toxins - An update

Journal of Toxicology - Toxin Reviews

Volumn 19, Issue 3-4, 2000, Pages 189-246

  Shier, W T ^a   Shier, A C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYSPHINGOSINE; ALTERNARIA ALTERNATA LYCOPERSICI TOXIN; AMINE; ANTIFUNGAL AGENT; CARBOXYL GROUP; CERAMIDE DERIVATIVE; CEREBROSIDE; FUMONISIN; FUMONISIN B1; GLYCOSPHINGOLIPID; SPHINGOSINE DERIVATIVE; THERMOZYMOCIDIN; TOXIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; FOOD CONTAMINATION; ISOLATION PROCEDURE; NONHUMAN; PHYTOTOXICITY; PROTEIN METABOLISM; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION; TOXIN ANALYSIS; TOXIN STRUCTURE; TOXIN SYNTHESIS;

EID: 0034508005     PISSN: 07313837     EISSN: None     Source Type: Journal    
DOI: 10.1081/TXR-100102321     Document Type: Review

References (189)

1. Aplidiasphingosine, an antimicrobial and antitumor terpenoid from an Aplidium sp. (Marine tunicate)
2. Inhibition of sphingolipid biosynthesis by fumonisins
3. Sphingosine analogs: An emerging new class of toxins that includes the fumonisins
4. Lysophingolipids inhibit protein kinase C: Implications for the sphingolipidoses
5. The sphingomyelin cycle and the second messenger function of ceramide
6. Sphingolipid breakdown products: Anti-proliferative and tumor-suppressor lipids
7. The role of ceramide in cell signaling
8. Ceramide in the eukaryotic stress response
9. Sphingosine-related marine alkaloids: Cyclic amino alcohols
10. Natural toxin series: (2) A sphingosine-like mycotoxin, fumonisin
11. Cytolytic Toxins
12. Phospholipases
13. Red blood cell lysis induced by the venom of the brown recluse spider: The role of sphingomyolinase D
14. Cytolytic mechanisms: Self-destruction of mammalian cells by activation of endogenous hydrolytic enzymes
15. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets
16. The sphingomyelin cycle: A prototypic sphingolipid signaling pathway
17. Programmed cell death induced by ceramide
18. Ceramide: An intracellular signal for apoptosis
19. Sphingolipid metabolism in the regulation of bioactive molecules
20. Introduction: Sphingolipids and their metabolites in cell regulation
21. The novel second messenger ceramide: Identification, mechanism of action, and cellular activity
22. Sphingolipid metabolites: Members of a new class of lipid second messengers
23. Sphingolipid-dependent protein kinases
24. Signal transduction through glyco(sphingo)lipids
25. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
26. Cancer-associated glycosphingolipid antigens: Their structure, organization, and function
27. An update of the enzymology and regulation of sphingomyelin metabolism
28. Sphingolipids - The enigmatic lipid class: Biochemistry, physiology and pathophysiology
29. Endogenous substrates of sphingosine-dependent kinases (SDKs) are chaperone proteins: Heat shock proteins, glucose-regulated proteins, protein disulfide isomerase, and calreticulin
30. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction
31. Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine other long-chain bases
32. Sphingolipids inhibit insulin and phorbol ester stimulated uptake of 2-deoxyglucose
33. Suppression of nerve growth factor-directed neurite outgrowth in PC12 cells by sphingosine, an inhibitor of protein kinase C
34. Inhibition of mouse B16 melanoma cell motility by sphingosine-1-phosphate eicosanoids and other bioactive lipids in cancer, inflammation, and radiation injury
35. Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGF and FCS mitogens
36. Intracellular calcium release mediated by sphingosine derivatives generated in cells
37. Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium
38. Increases in phosphatidic acid levels accompany sphingosine-stimulated proliferation of quiescent Swiss 3T3 cells
39. Inhibition of phosphatidic acid phosphohydrolase activity by sphingosine. Dual action of sphingosine in diacylglycerol signal termination
40. Sphingosine-1-phosphate rapidly activates the MAP kinase pathway by a G-protein dependent mechanism
41. Enzymatic synthesis of N,N-dimethyl-sphoingosine: Demonstration of the sphingosine: N-methylthansferase in mouse brain
42. A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation: Demonstration of its endogenous occurence (and the virtual absence of unsubstituted sphigosine) in human epidermoid carcinoma A431 cells
43. 3 in HL-60 cells. Role in cell differentiation
44. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts
45. Ceramide formation during heat shock: A potential mediator of αB-crystallin transcription
46. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells
47. Ceramide stimulates a cytosolic protein phosphatase
48. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown
49. Antitumor activity via inhibition of glycosphingolipid biosynthesis
50. Modulation of renal epithelial cell growth by glucosylceramide: Association with protein kinase C, sphingosine, and diacylglyceride
51. A sphingolipid having a novel type of ceramide and lacto-N-fucopentanose III
52. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody
53. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: Its possible identity with "A-like antigen" in human cancer
54. From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines
55. Preparation of a chemical vaccine against tumor progression
56. Modification of tumor growth with a defined glyco-protein antigen
57. Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling
58. Importance of glycolipid synthesis for butyric acid-induced sensitization to Shiga toxin and intracellular sorting of toxin in A431 cells
59. Disruption of the golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin and Pseudomonas toxin
60. Protein toxins: Mode of action and cell entry
61. Characterization of serine palmitoyltransferase activity in chinese hamster ovary cells
62. Fumonisins and other inhibitors of De Novo sphingolipid biosynthesis
63. Inhibition of serine palmitoyltransferase In Vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by beta-chloroalanine
64. Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase
65. Serine palmitoyltransferase is the primary target of a sphingosine-like immuno-suppressant, ISP-1/myriocin
66. Inhibition of serine palmitoyltransferase activity by lipoxamycin
67. Inhibition of sphingolipid biosynthesis by fumonisins
68. Alteration of serum sphingolipids upon dietary exposure of ponies to fumonisins, mycotoxins produced by Fusarium moniliforme
69. 1 cells
70. Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs
71. 1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: A new mechanism of nephrotoxicity
72. Fumonisin and AAL-toxin-induced disruption of sphingolipid metabolism with accumulation of free sphingoid bases
73. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity
74. N-palmitoyl-HFB 1: A new metabolite of hydrolyzed fumonisin (HFB1) in rat liver microsomes
75. Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolilte of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor
76. The discovery of auastralifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporomiella australis producing organism, fermentation, isolation, and biological activity
77. Glycolipid depletion using a ceramide analog (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells
78. Toxicity of the protien C inhibitor safingol administered alone and in combination with chemotherapeutic agents
79. (IS, 2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase
80. Two epimeric aliphatic amino alcohols from a sponge, Xestospongia sp.
81. Novel marine sponge amino acids, 10. Xestoaminols from Xestospongia sp.
82. Synthesis and absolute configuration of the two epimeric aliphatic amino alcohols [(5E, 7E)-2-amino-5,7-tetrade-cadien-3-ols] isolated from a sponge, Xestospongia sp.
83. The enantioselective synthesis and antiinflammatory activity of novel aryl-sphingolipid PKC inhibitors
84. Crucigasterins, new polyunsaturated amino alcohols from the mediterranean tunicate Pseudodistoma crucigaster
85. The structure of lipoxamycin, a novel antifungal antibiotic
86. Pseudodistomins A and B, novel antineoplastic piperidine alkaloids with calmodulin antagonistic activity from the Okinawan tunicate Pseudodistoma kanoko
87. Pseudodistomin B: Revised structure and first total synthesis
88. Pseudodistomin C, a new piperidine alkaloid with unusual absolute configuration from the Okinawan tunicate Pseudodistoma kanoko
89. Total synthesis of pseudodistomin C, a sphingosine-related piperidine alkaloid from tunicate Pseudodistoma kanoko
90. Penaresidin A and B, two novel azetidine alkaloids with potent actomyosin ATPase-activating activity from the Okinawan marine sponge Penares sp.
91. Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme
92. Stereoselective synthesis of penaresidin A and related azetidine alkaloids
93. Penazetidine A, an alkaloid inhibitor of protein kinase C
94. Clavepictines A and B: Cytotoxic quinolizidines from the tunicate Clavelina picta
95. Pictamine, a quinolizidine alkaloid from the tunicate Clavelina picta
96. A decahydroquinoline alkaloid from the tunicate Clavelina lepadiformis
97. Myriocin, a new antifungal antibiotic from Myriococcum albomyces
98. Elucidation of structure and stereochemistry of myriocin. A novel antifungal antibiotic
99. Isolation and structure determination of a new antifungal α-hydroxymethyl-α-amino acid
100. Crystal structure and relative configuration of the N-acetyl-γ-lactone of the antifungal antibiotic thermozymocidin
101. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite
102. Fungal metabolites. Part 14. Novel potent immunosuppressants, mycesterincins, produced by Mycelia sterilia
103. Total synthesis of (+)-thermozymocidin (myriocin) from D-fructose
104. 2-Benzoylamino-2-hydroxy-2-hydroxymethyl-D-hexono-1,4-lactones: Synthesis from D-fructose and utilization in the total synthesis of thermozymocidin (myriocin)
105. A new strategy for the synthesis of sphingosine analogues. Sphingofungin F
106. Fungal metabolites, Part 12. Potent immunosuppressant, 14-deoxomyriocin, (2S, 3R, 4R)-(E)-2-amino-3,4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives
107. Fumifungin, a new antifungal antibiotic from Aspergillus fumigatus fresenius 1863
108. Spingofungins A, B, C, and D; a new family of antifungal agents
109. Determination of the relative and absolute stereochemistry of sphingofungins A, B, C, and D
110. Sphingofungins E and F: Novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii
111. Phytotoxins. I. A 1-aminodimethyl-heptadecapentol from Alternaria alternata f. sp. Lycopersici
112. Phytotoxins. II. Characterization of a phytotoxic fraction from Alternaria alternata f. sp. Lycopersici
113. Fumonisins - Novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme
114. 1 to Lemna pausicostata
115. Biological activities of synthetic analogs of Alternaria alternata toxin (AAL-toxin) and fumonisin in plant and mammalian cell cultures
116. Rapid production of hyperplastic nodules in rats treated with carcinogenic chemicals: A new approach for an in vivo short-term screening test for hepatocarcinogens
117. Fumonisins: History, world-wide occurrence and impact
118. Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei
119. Detection of fumonisins produced in Fusarium moniliforme cultures by HPLC with electrospray MS and evaporative light scattering detectors
120. Isolation and characterization of two new type C fumonisins produced by Fusarium oxysporum
121. Identification of a new series of fumonisins containing 3-hydroxypyridine
122. Bildung von 1-alkyl-3-oxypyridini-umbetain aus Zuckern Z
123. Current research on mycotoxins: Fumonisins
124. Fungal toxins in food: Recent concerns
125. Natural occurrence of mycotoxins in foods feeds - An updated review
126. 1
127. 1, a toxic metabolite of Fusarium moniliforme
128. 1, in rats
129. 1 from the fungus Fusarium moniliforme causes contact toxicity in plants: Evidence from studies with biosynthetically labeled toxin
130. Toxicity of the mycotoxins fumonisins B1 and B2 and Alternaria alternata f. sp. lycopersici toxin (AAL) in cultured mammalian cells
131. 1
132. Fumonisin B1 stimulates arachidonic acid cascade by activation of mitogen-activated protein kinase
133. Activation of mitogen-activated protein kinase by fumonisin B1 stimulates cPLA2 phosphorylation, the arachidonic acid cascade and cAMP production
134. 1 induces protein kinase C translocation via direct interaction with diacylglycerol binding site
135. 1 in corn cultures of Fusarium proliferatum
136. Natural occurrence of fumonisins in rice with fusarium sheath rot disease
137. 1 in corn-containing foods
138. Toxicity of Fusarium proliferatum-fermented nixtamalized corn-based diets fed to rats: Effect of nutritional status
139. Analysis of fumonisin B1 and its hydrolysis product in tortillas
140. The fumonisin paradox: A review of research on oral bioavailability of fumonisin B1, a mycotoxin produced by Fusarium moniliforme
141. Rhizochalin, a novel secondary metabolite of mixed biosynthesis from the sponge Rhizochatina incrustata
142. Leucettamols A and B, two antimicrobial lipids from the calcareous sponge Leucetta microraphis
143. BRS1, A C30 Bis-amino, Bis-hydroxy polyunsaturated lipid from an Australian calcareous sponge that inhibits protein kinase C
144. Ceramides from the sponge Dysidea etheria
145. Occurence of Erythro-doccosasphinga-4, 8-dienine, as an ester, in Anemonia Sulcata
146. 2+-ATPase activator from the cultured dinoflagellate Symbiodinium sp.
147. 2+-ATPase activator from Symbiodinium sp.
148. 2+-ATPase activator from Symbiodinium sp.
149. New glycosphingolipids from marine organisms
150. A novel sphingosine derivative from the sponge Spirastrella inconstans
151. An acetylated derivative of a new N-acylsphingosine from red alga Halymenia porphyroides
152. A new sphingosine derivative from the red alga Halymenia durivilliae of Andaman and Nicobar Islands
153. An antiviral sphingosine derivative from the green alga Ulva Fasciata
154. A new sphingosine derivatives and a polyhydroxy steroidal glycoside from Sinularia gravis Tixier-Durivault of the Andaman and Nicobar Islands
155. Two new sphingosine derivative from Sinularia crassa Tixier-Durivault of the Andaman and Nicobar Islands
156. A novel sialoglycolipid from hepatopancreas of the starfish Patiria pectinifera
157. Isolation and structure of six new cerebrosides
158. Isolation and structure of two new ceramide lactosides
159. Isolation and structure of five new gangliosides
160. Strukturen eines neuen cerebrosidgemischs und von nucleosiden aus dem seestern Acanthaster planci
161. Isolation and characterization of acanthacerebroside B and structure elucidation of related, nearly homogeneous cerebrosides
162. Structure of three ganglioside molecular species and a homogeneous ganglioside, and biological activity of the ganglioside
163. Structures of three new cerebrosides, astrocerebroside A, B, and C and of related nearly homogeneous cerebrosides
164. KRN7000, a novel immunomodulator, and its antitumor activities
165. Antitumor activities of α-, β-monogalactosylceramides and four diastereomers of an α-galactosylceramide
166. Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus
167. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas Mauritianus
168. Longiside, a novel digalactosylceramide from the caribbean sponge Agelas longissima
169. Glycolipids from sponges. IV. Immunomodulating glycosyl ceramides from the marine sponge Agelas dispar
170. Axiceramide A an B, two novel Tri-α-glycosylceramides from the marine sponge Axinella sp.
171. Occurrence of ceramide digalactoside as the main glycosphingolipid in the marine sponge Halichondria japonica
172. Halicylindrosides, antifungal and cytotoxic cerebrosides from the marine sponge Halichondria cylindrata
173. Isolation and structure of cerebrosides from the sea cucumber Pentacta australis
174. Pharmacologically active substances from Southern Pacific marine invertebrates
175. Uber inhaltsstoffe von Euphorbiaceae, 9. Mitt. Neue cerebroside aus Euphorbia biglangulosa desf
176. Glucosylceramide having a novel tri-unsaturated long-chain base from the spermatozoa of the starfish, Asterias amurensis
177. Ophidiacerebrosides: Cytotoxic glycosphingolipids containing a novel sphingosine from a sea star
178. Isolation and structure of three new cerebrosides, CE-2b, CE-2c and CE-2d, from the sea cucumber Cucumaria echinata
179. Glycolipids from sponges. 6. Plakoside A and B, two unique prenylated glycosphingolipids with immunosuppressive activity from the marine sponge Plaakortis simplex
180. Effect of fumonisin mycotoxins in animals
181. Renal effects of fumonisin mycotoxins in animals
182. 1: Implications for food safety
183. 1 on weed and crop species
184. Structure-dependent phytotoxicity of fumonisins and related compounds in a duckweed bioassay
185. Biological activities of fumonisins, mycotoxins from Fusarium moniliforme, in jimsonweed (Datura stramonium L.) and mammalian cell cultures
186. Improved inhibitors of glucosylceramide synthase
187. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth